missing translation for 'onlineSavingsMsg'
Learn More
Learn More
PTP4A2 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Marca: Invitrogen PA550256
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
The antibody detects endogenous levels of total PTP4A2 protein.
PRL-2, also known as Protein tyrosine phosphatase 4a2 (Ptp4a2) is a unique nuclear protein tyrosine phosphatase (PTP) that plays a central role in regulating diverse cellular processes. PRL-1 is induced in mitogen-stimulated cells and regenerating liver. PRL-2 exhibits 87% identity to PRL-1 in their amino acid sequences. All mouse PRL proteins contain a C-terminal consensus sequence for prenylation. All PRL proteins bear significant sequence homology to Cdc14p and the tumor suppressor PTEN/MMAC1. PRL-2 is preferentially expressed in skeletal muscle. PRL-2 is also expressed at lower levels in other tissues.
Specifica
PTP4A2 | |
Polyclonal | |
Unconjugated | |
PTP4A2 | |
BM-008; HH13; HH7-2; HU-PP-1; OV-1; phosphatase of regenerating liver 2; PRL2; PRL-2; protein tyrosine phosphatase 4a2; protein tyrosine phosphatase IVA; protein tyrosine phosphatase IVA2; protein tyrosine phosphatase type IVA 2; protein tyrosine phosphatase type IVA, member 2; protein-tyrosine phosphatase 4a2; Protein-tyrosine phosphatase of regenerating liver 2; PTP(CAAXII); PTP4A; Ptp4a2; PTPCAAX2; ptp-IV1a; ptp-IV1b; tyrosine-phosphatase | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
19244, 8073, 85237 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.8 mg/mL | |
PBS with 40% glycerol and 0.05% sodium azide; pH 7.4 | |
O70274, Q12974, Q6P9X4 | |
PTP4A2 | |
Fusion protein corresponding to residues near the N terminal of human protein tyrosine phosphatase type IVA, member 2 | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto